Figure 6
Kaplan–Meier curves showing difference in survival probabilities between patients with PD and those without PD according to the rPPP. Analysis is conducted for: (a) SUVmean (b) SUVmax and (c) SUVpeak. The SUVpeak measurement used in this analysis is the PERCIST-recommended one—centered on the highest uptake part of the tumour with a spherical volume of 1 mL. The number of patients that are still at risk at a given time point, defined as those patients that have either not experienced death or been censored, are shown below each plot (time points in the table align with the x-axes of the plot).
